EXTRAWELL PHAR (00858) granted a total of 76.5 million warrants.

21:32 19/12/2025

Jingyou Pharmaceutical (00858) announced that on December 19, 2025, the company has granted a total of 76.5 million share options to three grantees (namely, Mr. Cheng Yong, Dr. Lou Yibao, and Dr. Guo Yibo, all of whom are executive directors) in accordance with its share option plan adopted on September 2, 2022. The exercise price of the share options is HK$0.0936 per share.

EXTRAWELL PHAR (00858) announced that on December 19, 2025, the company granted a total of 76.5 million stock options to three grantees (Mr. Cheng Yong, Dr. Lou Yibo, and Dr. Guo Yibo, all of whom are executive directors) in accordance with its stock option plan adopted on September 2, 2022. The exercise price of the stock options is HK$0.0936 per share.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families